Monitoring Progress of the STI National Strategic Plan

The cross-agency work group focused on implementing the STI National Strategic Plan 2021-2025 (STI Federal Implementation Working Group) continues to meet regularly to monitor progress, strategize about overcoming obstacles, and identify and capitalize on new opportunities or address emerging needs. In addition, the STI Federal Implementation Working Group develops progress reports, highlighting select accomplishments in implementing the National Strategic Plan. 

2021-2023 Progress Report

The STI Plan establishes seven core indicators to measure progress on meeting its goals. Four of the core indicators are stratified to measure progress toward reducing disparities within priority populations. The indicators were selected to measure national progress on STI prevention and care based on the available data and in alignment with other national plans, for example, Healthy People 2030. The table below presents overall progress for each indicator measure toward 2025 targets, based on the most recently available surveillance data from either 2021 or 2022. For more details, read the full 2021-2023 Progress Report.

2021-2023 STI Progress Report Thumbnail
Download the Progress Report - PDF

Overall Progress on STI National Strategic Plan Indicators toward 2025 Targets

Met or exceeded current annual target
Moving toward annual target, but annual target was not fully met
Annual target met, but data is moving away from overall 2025 target
Annual target was not met and has not changed or moved away from annual target
Data not available
Indicator Status
Core Indicators
1. Increase the percentage of adolescents aged 13–17 years who receive the routinely recommended doses of human papillomavirus (HPV) vaccine to 80% by 2025 Moving toward annual target, but annual target was not fully met
2. Reduce primary and secondary syphilis (P&S) syphilis rate by 3% by 2025 Annual target was not met and has not changed or moved away from annual target
3. Reduce congenital syphilis rate by 15% by 2025 Annual target was not met and has not changed or moved away from annual target
4. Reduce gonorrhea rate by 2% by 2025 Met or exceeded current annual target
5. Increase chlamydia screening in sexually active females aged 16–24 by 13% by 2025 Moving toward annual target, but annual target was not fully met
6. Reduce pelvic inflammatory disease (PID) in females aged 15–24 years by 6% by 2025 Data not available
7. Increase condom use at last sexual intercourse among sexually active high school students by 4% by 2025 Annual target met, but data is moving away from overall 2025 target
Disparities Indicators
8. Reduce P&S syphilis rate in gay, bisexual, and other men who have sex with men (MSM) Moving toward annual target, but annual target was not fully met
9. Reduce congenital syphilis rate among African Americans/Blacks Annual target was not met and has not changed or moved away from annual target
10. Reduce congenital syphilis rate among American Indians/Alaska Natives Annual target was not met and has not changed or moved away from annual target
11.  Reduce congenital syphilis rate in the West Annual target was not met and has not changed or moved away from annual target
12.  Reduce gonorrhea rate among African Americans/Blacks Met or exceeded current annual target
13.  Reduce gonorrhea rate in the South Moving toward annual target, but annual target was not fully met
14.   Increase condom use at last sexual encounter among sexually active MSM high school students Annual target was not met and has not changed or moved away from annual target
Content created by Office of Infectious Disease and HIV/AIDS Policy (OIDP)
Content last reviewed